SBT
1 FDA 510(k) clearances · Product code
FDA profile
- Official device name
- Device To Detect Microbial Colonization Directly From Clinical Specimens.
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 866.3967
- Medical specialty
- Microbiology
- FDA definition
- A device to detect microbial colonization directly from clinical specimens is a qualitative in vitro diagnostic device intended for the detection and identification of microbial-associated targets from patients who are suspected of being colonized with a microbial pathogen and may present a risk of transmission to other patients and health care workers. This device is intended to aid in the detection of microbial colonizers for the prevention and control of infection in healthcare settings when used in conjunction with clinical and laboratory findings.
Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free
| Record | Firm | Date |
|---|---|---|
| Simplexa C. auris Direct, Simplexa C. auris Positive Control Pack, Simplexa C. auris Sample Prep Kit (MOL3950, MOL3960, MOL5390) (DEN230092) | Diasorin Molecular, LLC | 2024-07-15 |
Track SBT automatically
Every clearance here is in the API, with alerts when new ones post.